Shannon L. Maude, MD, PhD, highlighted promising long-term disease-free survival and MRD negativity with tisagenleucel in high-risk pediatric ALL.
Shannon L. Maude, MD, PhD
Advertisement
Shannon L. Maude, MD, PhD, is an attending physician in the Cancer Center at the Children’s Hospital of Philadelphia.
Articles by Shannon L. Maude, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Special Report: The Oncology Care Model, 10 Years Later
2
FDA Approves Tocilizumab-bavi for CAR-T-Induced CRS, Pediatric COVID-19
3
AI Model Challenges Genomic Classifiers in Early Breast Cancer Risk Stratification: Nancy Lin, MD
4
Weight Loss Drugs Can Improve Outcomes in Patients With Heart Failure and Obesity: Sandra Chaparro, MD
5